At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
LithoVue Ureteroscope Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multi-center, Single-arm Study to Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease(LithoVue China Study)
In Brief
A clinical study evaluating LithoVue Ureteroscope System for Urinary Tract Disease. Completed, enrolled 60 participants across 3 sites.
Detailed Summary
To evaluate the safety and efficacy of LithoVue ureteroscope system in Chinese population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Tract Disease
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartDec 2018
Primary CompletionMay 2019
TodayJul 2026
First PostedSep 19, 2018
Enrollment StartDec 21, 2018
Primary CompletionMay 9, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.8 years ago
Interventions
LithoVue Ureteroscope Systemdevice
The LithoVue System is intended to be used to visualize organs, cavities and canals in the urinary tract (urethra, bladder, ureter, calyces and renal papillae) via transurethral or percutaneous access routes.